5-Chloromethyl-3-(4-nitro-phenyl)-[1,2,4]oxadiazole, 97.0%, 25g

Naphtho[2,1-b]furan-2-carboxylic acid, 95.0%, 5g

1-(Pyrimidin-2-yl)propan-1-amine, 95%, 500mg

2-Morpholino-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 98+%, 1g

Sodium orthosilicate, 25g

Methyl 4-(2-aminoacetyl)benzoate hydrochloride, 97%, 5g

1-Bromo-3,6,9,12-tetraoxapentadec-14-yne, 95%, 5g

6-ethylquinolin-4-ol, 95.0%, 1g

(E)-1-Octadecyl-4-styrylpyridin-1-ium bromide, 95+%, 1g

4,4'-Bis(2,2-diphenylvinyl)-1,1'-biphenyl, 99%, 200mg

Difenilammina, min 99%, pa, ACS, 100 g, confezione in vetro

anti-Uroplakin III monoclonale murino, AU1, 0,2 ml

Obiettivo piano Fluarex PLFi 100x/1.30 IOS corretto all'infinito. Distanza di lavoro 0,13 mm